Profound Medical Corp T.PRN

Concerns over new ways to fight cancer

[homer111]

Is anyone here worried how researchers are now using some of these mRNA vaccines (similar to the covid vaccines) to treat cancer and whether that may take some momentum away from PRN?

[HomerAndCompany]

From what I've read the use of mRNA to treat cancer is something that has been in the works for more than a decade. It's one of a number of new prostate cancer and BPH treatments that are or could be in competetion with Profound's TULSA.  I think that Profound revenues will be above $50 million when they achieve 1% of the US market, or a small fraction of 1% of the worldwide

[homer111]

Ok - thanks, from one homer to another... I know PRN has been down huge, with most other stocks currently, so I wasn't sure whether that was to do with new technologies/competition or whether they have been beaten down since they are still considered a 'speculative' stock, which are sometimes hit harder during times like these.

[HomerAndCompany]

The share price was more than halved within 2 months of the Sept 2 press reslease in which they put off their applicaton for a permant "CPT" billing code until 2023. Delays in acquiring a CPT code and in gaining traction in the market would appear to be responsible for the low SP. Perhaps that inspired some tax loss selling too. Competition is a concern in any market, but I think that